DTE vs HALO
DTE (DTE) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
DTE currently screens at market cap $0. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the DTE and HALO stock pages for the full models.
Not investment advice.